The levels of T cell differentiation subsets in patients with malignant tumors are lower than in healthy individuals.13 Immunoglobulins are the primary executors of humoral immune activities, and the levels of IgG, IgA, and IgM are closely associated with humoral immune response.14 In summary, both the cellular and humoral immune systems are affected when malignant tumors occur. Here, CD79A is linked to cancer.